Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-16

FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Mupirocin from Glenmark Pharmaceuticals Inc., USA. This approval updates the existing ANDA product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mupirocin (Mupirocin)

Snippet

SUPPL AP for MUPIROCIN (MUPIROCIN)